Descrizione del progetto
Coltivare professionisti nell’ambito del settore emergente della biomedicina computazionale
La pandemia di COVID-19 sta mettendo a dura prova i sistemi sanitari di tutto il mondo. Sussiste pertanto un’urgente necessità di aumentarne la capacità, aprendo la strada a ulteriori progressi nel campo della biomedicina. Alla luce di tali premesse, CompBioMed, un centro di eccellenza finanziato dall’UE, sta concentrando l’attenzione sull’impiego e sullo sviluppo di metodi computazionali per applicazioni biomediche. Costituito da membri provenienti dal mondo accademico, dall’industria e dal settore sanitario, questo centro funge da polo per i professionisti in tal ambito. Il progetto CompBioMed2, finanziato dall’UE, porterà CompBioMed alla prossima fase di innovazione biomedica in termini di sviluppo e perfezionamento di strategie mediche personalizzate. Questo progetto continuerà a sostenere, coltivare ed espandere la sua comunità di professionisti nell’ambito del settore emergente della biomedicina computazionale.
Obiettivo
CompBioMed2 is a proposal for the second phase of the Computational Biomedicine Centre of Excellence (CoE), CompBioMed, an outward facing CoE comprising members from academia, industry and the healthcare sector. CompBioMed has established itself as a hub for practitioners in the field, successfully nucleating a substantial body of research, education, training, innovation and outreach within the nascent field of Computational Biomedicine. Computational Biomedicine is an emergent technology that will enable clinicians to develop and refine personalised medicine strategies ahead of their clinical delivery to the patient. Medical regulatory authorities are currently embracing the prospect of using in silico methods in the area of clinical trials and we intend to be in the vanguard of this activity, laying the groundwork for the application of HPC-based Computational Biomedicine approaches to a greater number of therapeutic areas. The HPC requirements of our users are as diverse as the communities we represent. We support both monolithic codes, potentially scaling to the exascale, and complex workflows requiring support for advanced execution patterns. Understanding the complex outputs of such simulations requires both rigorous uncertainty quantification and the embrace of the convergence of HPC and high performance data analytics (HPDA). CompBioMed2 seeks to combine these approaches with the large, heterogeneous datasets from medical records and from the experimental laboratory to underpin clinical decision support systems. CompBioMed2 will continue to support, nurture and grow our community of practitioners, delivering incubator activities to prepare our most mature applications for wider usage, providing avenues that will sustain CompBioMed2 well-beyond the proposed funding period.
Parole chiave
Programma(i)
Invito a presentare proposte
(si apre in una nuova finestra) H2020-INFRAEDI-2018-2020
Vedi altri progetti per questo bandoBando secondario
H2020-INFRAEDI-2018-1
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
WC1E 6BT London
Regno Unito